These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 18573532)
1. Stress and glucocorticoid footprints in the brain-the path from depression to Alzheimer's disease. Sotiropoulos I; Cerqueira JJ; Catania C; Takashima A; Sousa N; Almeida OF Neurosci Biobehav Rev; 2008 Aug; 32(6):1161-73. PubMed ID: 18573532 [TBL] [Abstract][Full Text] [Related]
2. Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade? Aznar S; Knudsen GM J Alzheimers Dis; 2011; 23(2):177-93. PubMed ID: 21098983 [TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. McEwen BS Metabolism; 2005 May; 54(5 Suppl 1):20-3. PubMed ID: 15877308 [TBL] [Abstract][Full Text] [Related]
4. Late-life depression and Alzheimer's disease: the glutamatergic system inside of this mirror relationship. Frisardi V; Panza F; Farooqui AA Brain Res Rev; 2011 Jun; 67(1-2):344-55. PubMed ID: 21570126 [TBL] [Abstract][Full Text] [Related]
5. Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression. Hoogendijk WJ; Meynen G; Endert E; Hofman MA; Swaab DF Neurobiol Aging; 2006 May; 27(5):780.e1-780.e2. PubMed ID: 16198445 [TBL] [Abstract][Full Text] [Related]
6. Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis. Rasgon NL; Kenna HA Neurobiol Aging; 2005 Dec; 26 Suppl 1():103-7. PubMed ID: 16225963 [TBL] [Abstract][Full Text] [Related]
7. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Praticò D Ann N Y Acad Sci; 2008 Dec; 1147():70-8. PubMed ID: 19076432 [TBL] [Abstract][Full Text] [Related]
8. [Explicit and implicit memory for emotional stimuli in depressed elderly and Alzheimer's disease]. Ergis AM; Piolino P; Mure C Psychol Neuropsychiatr Vieil; 2003 Dec; 1(4):265-71. PubMed ID: 15683962 [TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction: A potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease? Isingrini E; Desmidt T; Belzung C; Camus V Curr Opin Investig Drugs; 2009 Jan; 10(1):46-55. PubMed ID: 19127486 [TBL] [Abstract][Full Text] [Related]
10. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Praticò D Trends Pharmacol Sci; 2008 Dec; 29(12):609-15. PubMed ID: 18838179 [TBL] [Abstract][Full Text] [Related]
11. Cerebrovascular and cardiovascular pathology in Alzheimer's disease. de la Torre JC Int Rev Neurobiol; 2009; 84():35-48. PubMed ID: 19501712 [TBL] [Abstract][Full Text] [Related]
12. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659 [TBL] [Abstract][Full Text] [Related]
13. Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study. Grünblatt E; Zehetmayer S; Bartl J; Löffler C; Wichart I; Rainer MK; Jungwirth S; Bauer P; Danielczyk W; Tragl KH; Riederer P; Fischer P J Psychiatr Res; 2009 Jan; 43(3):298-308. PubMed ID: 18603262 [TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Kidd PM Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347 [TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids. Mood, memory, and mechanisms. Wolkowitz OM; Burke H; Epel ES; Reus VI Ann N Y Acad Sci; 2009 Oct; 1179():19-40. PubMed ID: 19906230 [TBL] [Abstract][Full Text] [Related]
16. Hypothalamic vasopressin and oxytocin mRNA expression in relation to depressive state in Alzheimer's disease: a difference with major depressive disorder. Meynen G; Unmehopa UA; Hofman MA; Swaab DF; Hoogendijk WJ J Neuroendocrinol; 2009 Aug; 21(8):722-9. PubMed ID: 19500216 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications. El Khoury J; Luster AD Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047 [TBL] [Abstract][Full Text] [Related]
18. Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease. Targosz-Gajniak M; Siuda J; Ochudło S; Opala G J Neurol Sci; 2009 Aug; 283(1-2):79-82. PubMed ID: 19268974 [TBL] [Abstract][Full Text] [Related]
19. Gender-specific neuroimmunoendocrine aging in a triple-transgenic 3xTg-AD mouse model for Alzheimer's disease and its relation with longevity. Giménez-Llort L; Arranz L; Maté I; De la Fuente M Neuroimmunomodulation; 2008; 15(4-6):331-43. PubMed ID: 19047809 [TBL] [Abstract][Full Text] [Related]
20. Clusterin: a forgotten player in Alzheimer's disease. Nuutinen T; Suuronen T; Kauppinen A; Salminen A Brain Res Rev; 2009 Oct; 61(2):89-104. PubMed ID: 19651157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]